The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Is BPC 157 Legal? Understanding Its Status and Implications BPC 157 erectile dysfunction study: what the current evidence actually shows The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling